Table 49 Antileishmanial activity of compounds against amastigotes of Leishmania donovani in hamsters
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
| Compounds | Dose (mg/kg) | In vivo inhibition (%) | |
|---|---|---|---|
| Day-7 | Day-28 | ||
| g4 | 50 | 66 | – |
| g5 | 50 | 22 | 63 |
| g6 | 50 | 64 | – |
| g7 | 50 | 64 | – |